Board of Directors
Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.
Giovanni Caforio, MD
Chairman of the Board and Chief Executive Officer, Bristol Myers Squibb
Theodore R. Samuels
Lead Independent Director and Retired President of Capital Guardian Trust Company
Peter J. Arduini
President and Chief Executive Officer of GE Healthcare
Dr. Deepak L. Bhatt, MD, MPH
Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital; Professor of Medicine, Harvard Medical School
Julia A. Haller, MD
Ophthalmologist-in-Chief, Wills Eye Hospital
Manuel Hidalgo Medina, MD, PhD
Chief, Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York-Presbyterian /Weill Cornell Medical Center
Paula A. Price
Former Executive Vice President and Chief Financial Officer, Macy’s, Inc.
Derica W. Rice
Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark.
Gerald L. Storch
Chief Executive Officer, Storch Advisors
Karen H. Vousden, PhD
Senior Group Leader, The Francis Crick Institute and Chief Scientist, Cancer Research UK
Phyllis R. Yale
Advisory Partner, Bain & Company